Shanghai General Healthy Information and Technology Co. Ltd.

605186 · SHG · Healthcare / Medical Devices

20.69CNY-0.73 (-3.41%)

Price History

Full chart

Market Stats

Previous Close21.42

Open21.66

Day Range20.54 – 21.66

52-Week Range18.15 – 36.58

Volume1.06M

Market Cap3.35B

P/E (TTM)102.75

Forward P/E0.00

EPS0.24

Dividend Yield0.00%

Beta0.72

50-Day Avg25.56

200-Day Avg24.23

About

Shanghai General Healthy Information and Technology Co., Ltd. provides pharmaceutical logistics automation, information technology, and intelligent and mobile medical solutions in China. It operates through four segments: Smart Pharmacy Project, Intelligent Static Compounding Center Project, Intelligent Drug and Consumable Management Project, and Logistics and Mobile Robot Project. The company's products include the Smart Pharmacy Project, an intelligent drug management system that combines software and hardware; intelligent static distribution center project, an intelligent intravenous drug configuration and management system; and Intelligent Drug Consumables Management Project, a management system for drug consumables, including poisonous hemp drugs and high-value medical consumables. Shanghai General Healthy Information and Technology Co., Ltd. was founded in 2014 and is based in Shanghai, China.

Company Details

SectorHealthcare
IndustryMedical Devices
CEOMr. Jianwei Dai
Employees337
HeadquartersNo. 518, Zhongchen Road, Shanghai, China, 201613, China
Websitehttps://www.g-healthy.com

Leadership

Mr. Jianwei DaiChairman of the Board & GM · b. 1962
Mr. Hong QiuDeputy GM, CFO, Secretary of the Board of Directors & Director · b. 1980
Mr. Gang ChengExecutive VP & Director · b. 1973
Mr. Ling ZhaoDeputy GM & Director · b. 1977
Mr. Jianfeng LuoDeputy General Manager · b. 1976
Mr. Junhua ZhangDeputy General Manager · b. 1984
Mr. Weiyong GongDeputy General Manager · b. 1983
Ying ZhuAccounting Supervisor
Mr. Shaodeng WangSales Director · b. 1987

Financials

Income Statement

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	205.08M	233.05M	256.46M	300.24M	286.81M	489.76M	322.36M	307.56M	318.35M	345.49M
Growth (%)	-	+13.64%	+10.04%	+17.07%	-4.47%	+70.76%	-34.18%	-4.59%	+3.51%	+8.52%
Cost of Revenue	79.03M	92.20M	107.96M	131.83M	115.53M	282.38M	130.31M	138.97M	193.88M	194.58M
Gross Profit	126.05M	140.85M	148.49M	168.41M	171.28M	207.38M	192.05M	168.59M	124.47M	150.90M
Gross Margin	61.46%	60.44%	57.90%	56.09%	59.72%	42.34%	59.58%	54.82%	39.10%	43.68%
Operating Expense	68.16M	57.33M	44.00M	47.22M	47.73M	63.56M	59.98M	100.95M	87.18M	92.69M
Operating Income	57.89M	83.52M	104.49M	121.19M	123.55M	143.81M	132.07M	67.64M	37.29M	58.21M
Operating Margin	28.23%	35.84%	40.74%	40.37%	43.08%	29.36%	40.97%	21.99%	11.71%	16.85%
EBITDA	61.97M	84.89M	106.20M	123.25M	125.58M	147.25M	135.49M	73.89M	60.30M	58.99M
EBITDA Margin	30.22%	36.42%	41.41%	41.05%	43.78%	30.07%	42.03%	24.02%	18.94%	17.08%
Net Income	17.59M	55.40M	74.64M	91.90M	95.74M	117.62M	115.68M	60.00M	32.52M	30.78M
Net Income Margin	8.58%	23.77%	29.10%	30.61%	33.38%	24.02%	35.89%	19.51%	10.22%	8.91%
R&D	7.64M	12.21M	12.60M	17.76M	16.34M	23.20M	22.42M	23.37M	21.10M	21.73M
R&D as % of Total Revenue	3.72%	5.24%	4.91%	5.92%	5.70%	4.74%	6.95%	7.60%	6.63%	6.29%
Interest Expense	-	68.15K	78.40K	132.83K	230.55K	206.89K	77.20K	1.18M	3.12M	3.99M
Interest Expense % of Total Revenue	-	0.03%	0.03%	0.04%	0.08%	0.04%	0.02%	0.38%	0.98%	1.15%

Balance Sheet

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	256.67M	263.46M	355.39M	482.40M	997.40M	1.13B	1.20B	1.32B	1.47B	1.50B
Total Liabilities	96.99M	85.02M	99.83M	131.29M	119.79M	154.03M	115.58M	179.06M	305.43M	313.25M
Total Equity	117.30M	121.10M	195.73M	287.63M	813.15M	901.52M	1.00B	1.05B	1.07B	1.10B
Cash	94.23M	102.47M	133.86M	148.63M	559.88M	468.92M	366.27M	267.76M	123.84M	186.22M
Total Debt	-	-	2.02M	42.64M	11.90M	4.30M	6.55M	50.00M	126.25M	-
Net Debt	-94.23M	-102.47M	-131.84M	-105.99M	-547.98M	-464.61M	-359.72M	-217.76M	2.42M	-

Cash Flow

Currency: CNY	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	58.22M	57.01M	67.93M	76.03M	71.78M	53.83M	-37.26M	-35.39M	17.68M	96.72M
Investing Cash Flow	-4.12M	-844.96K	-23.73M	-96.56M	-60.90M	-107.95M	-84.87M	-102.61M	-189.13M	-
Financing Cash Flow	-24.07M	-47.93M	-13.42M	32.77M	403.39M	-37.05M	-12.24M	37.64M	59.84M	-
Capital Expenditure	4.98M	915.96K	23.74M	96.56M	60.91M	81.36M	66.72M	37.07M	136.61M	24.47M
Free Cash Flow	53.25M	56.10M	44.19M	-20.52M	10.87M	-27.54M	-103.98M	-72.47M	-118.93M	72.26M
Dividends Paid	19.00M	-	16.49M	9.86M	-	29.24M	12.24M	12.95M	16.41M	3.99M
FCF to OCF	91.45%	98.39%	65.05%	-26.99%	15.14%	-51.16%	279.06%	204.75%	-672.80%	74.70%
Dividend Paid to FCF	35.68%	-	37.33%	-48.06%	-	-106.19%	-11.77%	-17.87%	-13.80%	5.52%

Earnings

Report Date	Dec 31, 2020	Mar 31, 2021	Jun 30, 2021	Sep 30, 2021	Dec 31, 2021	Mar 31, 2022	Jun 30, 2022	Sep 30, 2022	Dec 31, 2022	Mar 31, 2023
EPS Estimate	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.27	0.05	0.33	0.19	0.29	0.05	0.35	0.23	0.22	0.07
Surprise	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	-	-	-	-	-

Key Statistics & Ratios

Market Cap3.35B

Enterprise Value3.73B

Trailing P/E102.75

Forward P/E0.00

Price / Sales9.03

Price / Book3.27

EPS0.24

Book Value8.16

Revenue (TTM)371.61M

Gross Profit (TTM)148.32M

EBITDA46.94M

Profit Margin8.84%

Operating Margin5.12%

Return on Equity2.50%

Return on Assets0.87%

Shares Outstanding136.00M

Shares Float67.65M

Beta0.72

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20241×

0.10Aug 23, 2024

20231×

0.09Aug 25, 2023

20221×

0.09Aug 25, 2022

20211×

0.21Aug 25, 2021